Haiti - Health : A vaccine will be tested in Haiti - HaitiLibre.com : Haiti news 7/7

Download the revised decree and electoral calendar, published in the official journal

iciHaiti - Infrastructure : 86 beneficiaries trained for the implementation of 5 projects in Baie de Henne

iciHaiti - Health : High-Level Meeting between DINEPA and UNICEF

Haiti - PNH : Plaques of honor and merit awarded to two Canadian Police Officers

iciHaiti - PNH : New operations to clear roads and dismantle gangs

iciHaiti - ONA : Opening of a new counter in Pétion-ville

more news

Haiti - FLASH : Violette AC crowned D1 champions of the 2025-2026 LHF season

Haiti - News : Zapping...

Haiti - Environment : Strategic meeting on strengthening climate data monitoring capacities

Haiti - Public Procurement : Strategic Agreement between UEH and Expertise France

Haiti - Cooperation : DINEPA meeting at the Cuban Embassy in Haiti

more news

Haiti - Health : A vaccine will be tested in Haiti
19/10/2011 14:09:48

The Ministry of Public Health and Population (MSPP) will soon conduct a test vaccination against cholera on a hundred subjects from a slum in Port-au-Prince and a rural community in the center of the country, where the disease was first identified in October 2010, according to information obtained by AFP from Dr. Gabriel Timothé, Director General of the Ministry of Health of Haiti.

The vaccine Shanchol will be administered orally to patients, in two doses. The vaccine approved by the World Health Organization (WHO) will not replace awareness among the population said Dr. Timothé.

There are 3 brands of vaccine against cholera in the world: Dukoral ($40 per dose) is manufactured in Sweden and approved by the WHO, Shanchol, now approved by WHO, ($6 per dose - $1,00 per dose with sufficient demand) is produced by Shantha Biotechnics in India and the Morc VAX-VaBiotech is produced in Vietnam.

International Vaccine Institute scientists developed this vaccine, with funding from the Bill & Melinda Gates Foundation, the Government of Korea, and the Swedish International Development Cooperation Agency (SIDA), by significantly modifying a vaccine used and produced only in Vietnam so that it meets international Good Manufacturing Practice (GMP) standards and WHO production guidelines.

The trial in Calcutta (India), which enrolled nearly 70,000 people, has shown that the vaccine provides 67% protection for at least two years in this highly-endemic population.

Vaccination against cholera, true or false hopes ?
https://www.haitilibre.com/en/news-1986-haiti-epidemic-vaccination-against-cholera-true-or-false-hopes.html

See also :
https://www.haitilibre.com/en/news-4053-haiti-health-cholera-already-one-year.html

HL/ HaitiLibre